Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phage probes for malignant glial cells.

Tatiana I Samoylova1, Valery A Petrenko, Nancy E Morrison

  • 1Scott-Ritchey Research Center and Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA. samoiti@vetmed.auburn.edu

Molecular Cancer Therapeutics
|November 18, 2003
PubMed
Summary

Researchers developed phage display to identify novel peptide ligands for targeting malignant glioma cells. This approach aids in creating molecular profiles for improved glioma detection and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Book Review.

Journal of wildlife diseases·2025
Same author

Discovery of Landscape Phage Probes Against Cellular Communication Network Factor 1 (CCN1/Cyr61).

Viruses·2025
Same author

Phage Display in Cancer Research: Special Issue Editorial.

Viruses·2024
Same author

Phage Display's Prospects for Early Diagnosis of Prostate Cancer.

Viruses·2024
Same author

Life-Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy.

Annals of neurology·2023
Same author

Rabies: who should care?

Journal of the American Veterinary Medical Association·2022

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Malignant gliomas are heterogeneous brain tumors.
  • Early diagnosis and treatment are hindered by challenges in characterizing tumor-specific molecules.

Purpose of the Study:

  • To develop molecular profiles for RG2 rat glioma cells using phage display technology.
  • To identify novel peptide ligands targeting malignant glioma cells.

Main Methods:

  • Phage display technology was employed to select peptide ligands from libraries.
  • Ligands were selected based on their binding affinity to RG2 glioma cells.
  • Three distinct families of peptide ligands were identified.

Main Results:

Related Experiment Videos

  • One ligand family targeted a common marker across glioma, normal brain, and non-brain cells.
  • A second ligand family exhibited glioma-selective properties.
  • A third ligand family, containing the RGD motif, showed efficient internalization by glioma cells (63-fold higher than astrocytes).

    • Conclusions:

    • Phage display is a viable approach for identifying glioma-specific ligands.
    • The identified ligands can aid in characterizing individual tumor expression patterns.
    • This method holds potential for designing targeted anti-glioma therapies.